A bill to amend the Public Health Service Act to establish an Office of Rare Diseases at the National Institutes of Health, and for other purposes.
Sets forth the duties of such Office and regional centers, including research and educational duties.
Title II: Food and Drug Administration - Amends the Orphan Drug Act to authorize a specified amount of appropriations for FY 2002 and such sums as may be necessary for subsequent fiscal years for grants and contracts for the development of drugs for rare diseases and conditions.
Became Public Law No: 107-280.
Introduced in Senate
Sponsor introductory remarks on measure. (CR S8952)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Kennedy with an amendment in the nature of a substitute. With written report No. 107-129.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Kennedy with an amendment in the nature of a substitute. With written report No. 107-129.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 298.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line